Company: INSP
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001609550-25-000020
Chunk: 19

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 1
Chunk 19
---
 included in accumulated other comprehensive income within stockholders' equity in the consolidated balance sheets. We had $0.1 million of unrecognized loss and $0.2 million of unrecognized gain in our accumulated other comprehensive income balance as of March 31, 2025 and December 31, 2024, respectively.

9

Table of ContentsInspire Medical Systems, Inc. Notes to Consolidated Financial Statements (unaudited) (Table amounts in thousands, except share and per share amounts)

InvestmentsOur investments are classified as available-for-sale and consisted of the following:March 31, 2025AmortizedUnrealized GrossAggregateCostGainsLossesFair ValueShort-Term:Commercial paper$13,422 $13 $— $13,435 Corporate debt securities49,630 90 (4)49,716 Certificates of deposit2,994 5 — 2,999 U.S. treasury debt securities249,016 179 (38)249,157 Short-term investments$315,062 $287 $(42)$315,307 Long-Term:Corporate debt securities$25,820 $60 $(13)$25,867 Asset-backed securities158 — — 158 U.S. treasury debt securities18,736 70 — 18,806 Long-term investments$44,714 $130 $(13)$44,831 December 31, 2024AmortizedUnrealized GrossAggregateCostGainsLossesFair ValueShort-Term:Commercial paper$19,806 $25 $— $19,831 Corporate debt securities47,226 80 (7)47,299 Certificates of deposit7,684 10 — 7,694 U.S. treasury debt securities220,283 346 (57)220,572 Short-term investments$294,999 $461 $(64)$295,396 Long-Term:Corporate debt securities$23,915 $59 $(49)$23,925 Asset-backed securities287 — — 287 U.S. treasury debt securities46,818 50 (85)46,783 Long-term investments$71,020 $109 $(134)$70,995 The following table shows all available-for-sale investments in an unrealized loss position for which an allowance for credit losses has not been recorded and the related gross unrealized loss